Developer docs
API playgroundTry for free, no card

Search company profiles

ACI Biosciences

Full company profile

uuid000ie7d

Namestring
ACI Biosciences
Legal namestring
ACI Biosciences
Company typeenum
Private
Founded yearint
2000
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersChevy Chase, United States
HQ citystring
Chevy Chase
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary contract research, animal health product development, veterinary clinical trials, pharmaceutical CMC services, translational medicine research
Industry3 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Pharmaceutical Preparations2834
  • Biological Products, (No Disgnostic Substances)2836
Product category
Veterinary Contract Research and Product Development Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Contract Research Services
TypeProfessional Services
Description

ACI Biosciences provides product development services for pharmaceuticals and biologicals to animal health industry sponsors. Services include study design, regulatory guidance, clinical trial conduct, pharmacokinetics/pharmacodynamics analyses, and full development programs.

acibiosciences.com
2CMC Solutions
TypeProfessional Services
Description

Chemistry, Manufacturing and Controls professional services including project management, API process chemistry, formulation development, manufacturing process development, analytical methods, quality assurance/control, regulatory guidance, and process validation.

acibiosciences.com
3Clinical Trial Conduct
TypeProfessional Services
Description

Sponsored clinical trials funded by animal health companies seeking regulatory approval for new veterinary products. ACI conducts multicenter, randomized, placebo-controlled clinical studies.

acibiosciences.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ACI Biosciences provides contract research and product development services to animal health pharmaceutical and biotech sponsors. Offerings encompass GCP-compliant clinical trial design and conduct, regulatory guidance and submissions, CMC (chemistry, manufacturing and controls) solutions, pharmacokinetics/pharmacodynamics analyses, and translational medicine leveraging comparative oncology. The company delivers work through an established network of board-certified veterinary specialists and general practitioners in the US, Canada, and Brasil.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 23+ years of veterinary product development experience since October 2000
+3 more records
Product overview1 text field

ACI Biosciences is a comprehensive product development services company for animal health, offering an integrated platform of services including Research & Development (study conduct, regulatory submissions, pharmacokinetics/pharmacodynamics), CMC Solutions (chemistry, manufacturing, controls, analytical development), and Translational Medicine. The company operates through an established network of clinical investigators and subject matter experts, providing services from pre-clinical through post-market stages for pharmaceuticals, biologicals, and vaccines. ACI Brasil extends these capabilities to Brazil. The core offering is service-based product development rather than a singular software product.

Product and service3 records
1Research & Development Services
CategoryContract Research / Clinical Development
Description

Comprehensive product development services for pharmaceuticals, biologicals, and vaccines for animal health, including GCP-compliant study conduct, pharmacokinetics/pharmacodynamics analyses, regulatory guidance and submissions, and new product development planning for animal health industry sponsors.

2CMC Solutions
CategoryPharmaceutical Development / CMC
Description

Chemistry, Manufacturing and Controls professional services covering API process chemistry, formulation and manufacturing process development, analytical methods development and validation, quality assurance and quality control, regulatory guidance, and process validation from concept through commercial launch for animal health sponsors.

3Translational Medicine
CategoryTranslational Research
Description

Translational clinical research services leveraging comparative oncology expertise to advance product candidates that may benefit both people and their pets, bridging safety and effectiveness across species for animal health sponsors and the translational medicine research community.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Board-Certified Veterinary Specialists and General Practitioners
Strategic tierCoreTypeOthers
Description

ACI Biosciences has established a well-trained network of board-certified veterinary specialists and general practitioners in private practice and academic medicine across the United States, Canada, and Brasil. These investigators provide unparalleled access to expertise for clinical study conduct and product development support. The network includes specialists in oncology, internal medicine, surgery, and other veterinary disciplines.

acibiosciences.com
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

ACI Biosciences manages relationships with Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs) for API manufacturing, formulation development, and GMP production. The CMC team provides comprehensive management of these relationships ensuring seamless communication, supplier oversight, and alignment of development plans.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global CRO with clinical development and regulatory services. Selected by animal-health sponsors for larger pivotal trials where global infrastructure matters.

TypeEmerging player
Description

Preclinical and clinical research organization offering animal model and safety assessment services. Overlaps with ACI on preclinical and translational work for animal health products.

TypeBroad incumbent
Description

Large clinical CRO spun out from Labcorp. Competes for veterinary clinical trial work where global site network and central lab scale are required.

TypeOthers
Description

Largest animal health pharma company and likely ACI sponsor or potential in-houser of CRO capabilities. Not a direct competitor but a key counterparty that shapes demand for veterinary CRO services.

TypeBroad incumbent
Description

Large CRO owned by Thermo Fisher covering full clinical development lifecycle. Competes for animal-health sponsors' pivotal trials alongside ICON, Parexel, and Labcorp.

6ClinVet International
TypeDirect peer
Description

South Africa-based veterinary CRO offering preclinical and clinical development services for animal health products. Direct competitor in the veterinary CRO niche with comparable target market and service mix.

TypeDirect peer
Description

Contract research and manufacturing organization focused on animal health and skin health product development. Directly competes for veterinary pharma and biologics development mandates.

TypeBroad incumbent
Description

Large global CRO/CDMO covering discovery through clinical development. Competes for veterinary pharma sponsors seeking broad development capabilities, though its core focus is human health.

TypeBroad incumbent
Description

Global clinical CRO with extensive Phase I-IV trial capabilities. Competes for veterinary clinical trial engagements and offers comparable sponsor-facing professional services.

TypeBroad incumbent
Description

Global CRO/CDMO offering preclinical, clinical, and manufacturing services across human and animal health. Competes for end-to-end veterinary product development work via its Research Models & Services and CDMO segments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ACI Biosciences

Veterinary Contract Research and Product Development Servicesacibiosciences.com

ACI Biosciences firmographics

Firmographics
Name
ACI Biosciences
Legal name
ACI Biosciences
Website
https://acibiosciences.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

ACI Biosciences industry classification

Industry
Product category
Veterinary Contract Research and Product Development Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Veterinary contract research
  • Animal health product development
  • Veterinary clinical trials
  • Pharmaceutical CMC services
  • Translational medicine research

Where ACI Biosciences is headquartered

Location

Headquarters

HQ city
Chevy Chase
HQ country
United States
HQ region
North America

Offices3 records

Markets served

ACI Biosciences business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Contract Research Services: ACI Biosciences provides product development services for pharmaceuticals and biologicals to animal health industry sponsors. Services include study design, regulatory guidance, clinical trial conduct, pharmacokinetics/pharmacodynamics analyses, and full development programs.
  2. CMC Solutions: Chemistry, Manufacturing and Controls professional services including project management, API process chemistry, formulation development, manufacturing process development, analytical methods, quality assurance/control, regulatory guidance, and process validation.
  3. Clinical Trial Conduct: Sponsored clinical trials funded by animal health companies seeking regulatory approval for new veterinary products. ACI conducts multicenter, randomized, placebo-controlled clinical studies.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

ACI Biosciences product offering

Product offering

Core offering

ACI Biosciences provides contract research and product development services to animal health pharmaceutical and biotech sponsors. Offerings encompass GCP-compliant clinical trial design and conduct, regulatory guidance and submissions, CMC (chemistry, manufacturing and controls) solutions, pharmacokinetics/pharmacodynamics analyses, and translational medicine leveraging comparative oncology. The company delivers work through an established network of board-certified veterinary specialists and general practitioners in the US, Canada, and Brasil.

Product overview

ACI Biosciences is a comprehensive product development services company for animal health, offering an integrated platform of services including Research & Development (study conduct, regulatory submissions, pharmacokinetics/pharmacodynamics), CMC Solutions (chemistry, manufacturing, controls, analytical development), and Translational Medicine. The company operates through an established network of clinical investigators and subject matter experts, providing services from pre-clinical through post-market stages for pharmaceuticals, biologicals, and vaccines. ACI Brasil extends these capabilities to Brazil. The core offering is service-based product development rather than a singular software product.

Differentiator

Problem solved

Functional benefit

Products and services

  • Research & Development Services Comprehensive product development services for pharmaceuticals, biologicals, and vaccines for animal health, including GCP-compliant study conduct, pharmacokinetics/pharmacodynamics analyses, regulatory guidance and submissions, and new product development planning for animal health industry sponsors.
  • CMC Solutions Chemistry, Manufacturing and Controls professional services covering API process chemistry, formulation and manufacturing process development, analytical methods development and validation, quality assurance and quality control, regulatory guidance, and process validation from concept through commercial launch for animal health sponsors.
  • Translational Medicine Translational clinical research services leveraging comparative oncology expertise to advance product candidates that may benefit both people and their pets, bridging safety and effectiveness across species for animal health sponsors and the translational medicine research community.

Quantifiable outcome

  • 23+ years of veterinary product development experience since October 2000
  • +3 more outcomes

Companies that use ACI Biosciences

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles1 record

ACI Biosciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

ACI Biosciences partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Board-Certified Veterinary Specialists and General PractitionerscoreOthersACI Biosciences has established a well-trained network of board-certified veterinary specialists and general practitioners in private practice and academic medicine across the United States, Canada, and Brasil. These investigators provide unparalleled access to expertise for clinical study conduct and product development support. The network includes specialists in oncology, internal medicine, surgery, and other veterinary disciplines.
  • CMO/CDMO PartnerscoreImplementation/ SI/ Consulting PartnerACI Biosciences manages relationships with Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs) for API manufacturing, formulation development, and GMP production. The CMC team provides comprehensive management of these relationships ensuring seamless communication, supplier oversight, and alignment of development plans.

Scale indicators5 records

Recent moves9 records

Expansion highlights6 records

ACI Biosciences competitors and assessment

Company assessment

Broad incumbents

  • Parexel International: Global CRO with clinical development and regulatory services. Selected by animal-health sponsors for larger pivotal trials where global infrastructure matters.
  • Labcorp Drug Development (Fortrea): Large clinical CRO spun out from Labcorp. Competes for veterinary clinical trial work where global site network and central lab scale are required.
  • PPD (Thermo Fisher Scientific): Large CRO owned by Thermo Fisher covering full clinical development lifecycle. Competes for animal-health sponsors' pivotal trials alongside ICON, Parexel, and Labcorp.
  • WuXi AppTec: Large global CRO/CDMO covering discovery through clinical development. Competes for veterinary pharma sponsors seeking broad development capabilities, though its core focus is human health.
  • ICON plc: Global clinical CRO with extensive Phase I-IV trial capabilities. Competes for veterinary clinical trial engagements and offers comparable sponsor-facing professional services.
  • Charles River Laboratories: Global CRO/CDMO offering preclinical, clinical, and manufacturing services across human and animal health. Competes for end-to-end veterinary product development work via its Research Models & Services and CDMO segments.

Emerging players

  • Inotiv: Preclinical and clinical research organization offering animal model and safety assessment services. Overlaps with ACI on preclinical and translational work for animal health products.

Others

  • Zoetis: Largest animal health pharma company and likely ACI sponsor or potential in-houser of CRO capabilities. Not a direct competitor but a key counterparty that shapes demand for veterinary CRO services.

Direct peers

  • ClinVet International: South Africa-based veterinary CRO offering preclinical and clinical development services for animal health products. Direct competitor in the veterinary CRO niche with comparable target market and service mix.
  • Argenta (Galderma): Contract research and manufacturing organization focused on animal health and skin health product development. Directly competes for veterinary pharma and biologics development mandates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ACI Biosciences social profiles

Digital presence

ACI Biosciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ACI Biosciences leadership team

Management profile

Number of profiles

Profiles15 records

ACI Biosciences subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

ACI Biosciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ACI Biosciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACI Biosciences

What does ACI Biosciences do?

ACI Biosciences provides contract research and product development services to animal health pharmaceutical and biotech sponsors. Offerings encompass GCP-compliant clinical trial design and conduct, regulatory guidance and submissions, CMC (chemistry, manufacturing and controls) solutions, pharmacokinetics/pharmacodynamics analyses, and translational medicine leveraging comparative oncology. The company delivers work through an established network of board-certified veterinary specialists and general practitioners in the US, Canada, and Brasil.

Is ACI Biosciences a public or private company?

ACI Biosciences is a private company. It is classified as family owned and is currently operating.

When was ACI Biosciences founded?

ACI Biosciences was founded in 2000. It employs 11 to 50 people.

Where is ACI Biosciences based?

ACI Biosciences is headquartered in Chevy Chase, United States, in the North America region.

How does ACI Biosciences make money?

Three revenue lines are on record. Contract Research Services are the primary driver. The others are CMC Solutions and clinical Trial Conduct.

Who are ACI Biosciences's main competitors?

Broad incumbents on record are Parexel International, Labcorp Drug Development (Fortrea), PPD (Thermo Fisher Scientific), WuXi AppTec, ICON plc and Charles River Laboratories. Inotiv is listed as an emerging player. Zoetis is listed as an others. Direct peers are ClinVet International and Argenta (Galderma).

Does ACI Biosciences have an API?

No public API is recorded for ACI Biosciences.

What industry is ACI Biosciences in?

ACI Biosciences's product category is Veterinary Contract Research and Product Development Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales